ASGP‐R can also be viewed as an index to reflect the level of liver fibrosis giving galactose‐modified delivery systems potential in anti‐fibrotic therapies for diagnosis of the degree of liver fibrosis based on the accumulation of galactose in hepatocytes. This evidence concerns the gene ASGR1 and Hepatic fibrosis.